Actuate Therapeutics plans to sell 5.56 million shares at between $8 and $10 apiece on the Nasdaq. Learn more about what the company does in this story and get its latest financials.
Holden Wilen, Biz Journals
Mon, 06/24/2024 - 9:46pm
Actuate Therapeutics plans to sell 5.56 million shares at between $8 and $10 apiece on the Nasdaq. Learn more about what the company does in this story and get its latest financials.